BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16271500)

  • 1. Transforming growth factor-beta signalling in brain disorders.
    Vivien D; Ali C
    Cytokine Growth Factor Rev; 2006; 17(1-2):121-8. PubMed ID: 16271500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Does transforming growth factor-beta (TGF-beta) act as a neuroprotective agent in cerebral ischemia?].
    Docagne F; Ali C; Lesne S; Nicole O; MacKenzie ET; Buisson A; Vivien D
    J Soc Biol; 2003; 197(2):145-50. PubMed ID: 12910629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: the breaking open of a black box.
    Alevizopoulos A; Mermod N
    Bioessays; 1997 Jul; 19(7):581-91. PubMed ID: 9230691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta signalling and immunity in prostate tumourigenesis.
    Diener KR; Need EF; Buchanan G; Hayball JD
    Expert Opin Ther Targets; 2010 Feb; 14(2):179-92. PubMed ID: 20055717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Signaling pathways of transforming growth factor beta family members].
    Zimowska M
    Postepy Biochem; 2006; 52(4):360-6. PubMed ID: 17536504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta (TGF-beta) and programmed cell death in the vertebrate retina.
    Duenker N
    Int Rev Cytol; 2005; 245():17-43. PubMed ID: 16125544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
    Santander C; Brandan E
    Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon.
    Roussa E; Wiehle M; Dünker N; Becker-Katins S; Oehlke O; Krieglstein K
    Stem Cells; 2006 Sep; 24(9):2120-9. PubMed ID: 16741229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptor requirements for the induction of the endothelin-1 gene.
    Castañares C; Redondo-Horcajo M; Magan-Marchal N; Lamas S; Rodriguez-Pascual F
    Exp Biol Med (Maywood); 2006 Jun; 231(6):700-3. PubMed ID: 16740983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between IGF-I and TGF-beta signaling pathways.
    Danielpour D; Song K
    Cytokine Growth Factor Rev; 2006; 17(1-2):59-74. PubMed ID: 16297654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
    Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
    Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions.
    Santibañez JF; Quintanilla M; Bernabeu C
    Clin Sci (Lond); 2011 Sep; 121(6):233-51. PubMed ID: 21615335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
    Van Aarsen LA; Leone DR; Ho S; Dolinski BM; McCoon PE; LePage DJ; Kelly R; Heaney G; Rayhorn P; Reid C; Simon KJ; Horan GS; Tao N; Gardner HA; Skelly MM; Gown AM; Thomas GJ; Weinreb PH; Fawell SE; Violette SM
    Cancer Res; 2008 Jan; 68(2):561-70. PubMed ID: 18199553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
    Levy L; Hill CS
    Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between the aryl hydrocarbon receptor and transforming growth factor-beta signaling pathways: evidence of an asymmetrical relationship in rat granulosa cells.
    Bussmann UA; Barañao JL
    Biochem Pharmacol; 2008 Oct; 76(9):1165-74. PubMed ID: 18786509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
    Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
    Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.
    Li M; Becnel LS; Li W; Fisher WE; Chen C; Yao Q
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):381-7. PubMed ID: 16314822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
    Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.